News and Announcements
Why Is It Attractive To Invest In Australia’s Startups
- Published December 20, 2022 2:06AM UTC
- Publisher Leila Oliveira
- Categories Capital Raising Tips
There has never been a more exciting time to be an Australian startup founder,
investor, or ecosystem participant.
If you don’t believe it, let me show you some data:
1️⃣ Australian startups received more than $10 billion in funding in 2021 -3x more than 2020
2️⃣There were more $100M+ rounds in 2021 than in the prior three years combined, and more $250M+ rounds than in the entire history of the Australian ecosystem.
3️⃣ 682 deals were announced – a 66% increase from 2020
There are more world-class Australian startups being launched, more local investors with more capital to deploy than ever, and more international investors hunting for
Australian deals.
Exciting times ahead!
[tomorrow at 8:00AM Sydney time, I’ll post a breakdown of the top 5 sectors that raised 50% of the total raised in 2021]
via: The state of Australian Startup Funding 2021 report
Looking for a platform to raise capital? Click here to discover how Wholesale Investor can help you.
Your capital engagement platform
With a 14-year track record, a network of 32,000+ investors, and a capital raising platform, Wholesale investor is a leading investment platform for start-ups, scale-ups, emerging growth companies, and small caps.
Capital Raising Tips
The Biofilm Breakthrough: How An Australian BioTech Firm Is Tapping Indonesia’s $45,000-a-Kitchen Bottleneck
Australian sustainability and deep-tech firm Altair International Pty Ltd is commercialising plant-based clinical hygiene technology, targeting a prime operational bottleneck in Indonesia’s massive national free meals program. Every few years, an Australian deep-tech company emerges combining proprietary science with a transformational anchor contract, the kind of business that quietly creates an entirely new market category […]
THE TAX CHANGED. NOW THE PRODUCT IS CHANGING TO MATCH.
Changes to the 50% capital gains tax discount are shifting Australian private capital away from growth and into high-yielding wrappers. Fund managers are actively redesigning products across private credit and property to capture the incoming capital rotation
The Algorithm Re-Dosing Cancer Treatment: Inside the University of Melbourne Spin-Out Rewriting a 60-Year-Old Formula
Oncology specialists are still calculating toxic chemotherapy doses using a formula from the era of the Ford Model T, leading to a system where seven out of eight patients are routinely overdosed. University of Melbourne spin-out PredicTx is dismantling this legacy approach, utilizing advanced AI to analyze existing patient CT scans, deliver precision medicine to the bedside, and return a massive 100x financial rerate to hospital networks.
Backed By Leading Investment Groups and Family Offices
